Showing results (271-280 of 321) with videos related to
Sort By:
Pageof 33
Haematologica|October 1, 2013
Autologous transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia achieves outcomes similar to allogeneic transplantation: results of CALGB Study 10001 (Alliance)Meir Wetzler, Dorothy Watson, Wendy Stock, et al.Blood|August 26, 1998
A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111R A Larson, R K Dodge, C A Linker, et al.Frontiers in Immunology|May 23, 2019
MAdCAM-1-Mediated Intestinal Lymphocyte Homing Is Critical for the Development of Active Experimental Autoimmune EncephalomyelitisKristina Kuhbandner, Anna Hammer, Stefanie Haase, et al.Molecular Neurodegeneration|November 16, 2014
Increase of angiotensin II type 1 receptor auto-antibodies in Huntington's diseaseDe-Hyung Lee, Harald Heidecke, Alexandra Schröder, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 4, 2000
High-dose chemotherapy and hematopoietic stem cell rescue for breast cancer: experience in CaliforniaL E Damon, W W Hu, K E Stockerl-Goldstein, et al.Stroke|September 28, 2019
Siponimod (BAF-312) Attenuates Perihemorrhagic Edema And Improves Survival in Experimental Intracerebral HemorrhageTobias Bobinger, Anatol Manaenko, Petra Burkardt, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2009
Immunochemotherapy and autologous stem-cell transplantation for untreated patients with mantle-cell lymphoma: CALGB 59909Lloyd E Damon, Jeffrey L Johnson, Donna Niedzwiecki, et al.Journal of Neurology|April 27, 2018
Alemtuzumab as rescue therapy in a cohort of 50 relapsing-remitting MS patients with breakthrough disease on fingolimod: a multi-center observational studyKonstantin Huhn, Antonios Bayas, Sebastian Doerck, et al.Leukemia Research|August 24, 1999
Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute myelogenous leukemia in 1st remissionR P Gale, R E Park, R W Dubois, et al.Journal of the Neurological Sciences|January 30, 2023
Cerebrospinal fluid in Borna disease virus 1 (BoDV-1) encephalitisBernhard Neumann, Andreas Hierl, Silke Wunderlich, et al.Pageof 33